No Data
Twist Bioscience Expands Universal Adapter Portfolio With Launch of High Throughput UDI Adapter System
Leerink Partners Sticks to Its Hold Rating for Twist Bioscience (TWST)
Express News | Twist Bioscience Corp : Leerink Partners Cuts Target Price to $40 From $48
Press Release: Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Cuts Target Price to $45